Patrick Taylor Horn's Net Worth
$1.68 Million
Who is Patrick Taylor Horn?
Patrick Taylor Horn has an estimated net worth of $1.68 Million. This is based on reported shares across multiple companies, which include TETRAPHASE PHARMACEUTICALS INC, and ALBIREO PHARMA, INC..
SEC CIK
Patrick Taylor Horn's CIK is 0001572002
Past Insider Trading and Trends
2015 was Patrick Taylor Horn's most active year for acquiring shares with 5 total transactions. Patrick Taylor Horn's most active month to acquire stocks was the month of December. 2015 was Patrick Taylor Horn's most active year for disposing of shares, totalling 8 transactions. Patrick Taylor Horn's most active month to dispose stocks was the month of June. 2017 saw Patrick Taylor Horn paying a total of $20,300.00 for 180,000 shares, this is the most they've acquired in one year. In 2015 Patrick Taylor Horn cashed out on 80,000 shares for a total of $1,752,200.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TETRAPHASE PHARMACEUTICALS INC No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
$2.03 | $20,300.00 | 10K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
$23.36 | -$426,600.00 |
0
|
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$25.48 | -$469,000.00 |
0
|
Scheduled
|
Jul 13
| ||
Form 4
|
—
|
0
|
$21.88 | -$396,900.00 |
0
|
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$20.96 | -$378,500.00 |
0
|
Scheduled
|
May 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALBIREO PHARMA, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.76% | -95.00 |
$28.83 | -$2,738.85 | 12.36K |
Scheduled
|
Oct 22
| ||
Form 4
| -0.72% | -90.00 |
$34.13 | -$3,071.70 | 12.45K |
Scheduled
|
Jul 22
| ||
Form 4
| -0.75% | -90.00 |
$31.75 | -$2,857.50 | 11.89K |
Scheduled
|
Apr 22
| ||
Form 4
| +121.53% | 5.39K |
$34.62 | -$3,808.20 | 9.82K |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
| -2.03% | -89.00 |
$34.55 | -$3,074.95 | 4.29K |
Scheduled
|
Oct 22
| ||
Form 4
| -2.04% | -91.00 |
$25.80 | -$2,347.80 | 4.37K |
Scheduled
|
Jul 22
| ||
Form 4
| -2.02% | -92.00 |
$17.64 | -$1,622.88 | 4.46K |
Scheduled
|
Apr 22
| ||
Form 4
| -8.86% | -443.00 |
$24.29 | -$10,760.47 | 4.56K |
Scheduled
|
Jan 21 - Jan 22
| ||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||